Rate My Professor Graham Hillis

Graham Hillis is Clinical Professor of Medicine in the UWA Medical School at the University of Western Australia and Head of the Department of Cardiology at Royal Perth Hospital since 2015. He earned his MBChB and BMedBiol degrees from the University of Aberdeen in 1990, followed by a PhD in Medicine from the same university in 1998. After basic medical training and his PhD at Aberdeen, he completed cardiology training in Edinburgh, including a one-year British Heart Foundation fellowship at the Mayo Clinic in Rochester, USA. From 2002 to 2008, he was Senior Lecturer in Cardiology and Consultant Cardiologist at the University of Aberdeen and Aberdeen Royal Infirmary. In 2008, he relocated to Sydney, serving as a cardiologist at Concord Repatriation General Hospital, Strathfield Private Hospital, and Royal Prince Alfred Hospital Medical Centre, and as Director of the Cardiovascular Division at The George Institute for Global Health from 2010 to 2015. He holds additional positions as Adjunct Professor at Curtin University since 2018 and Professorial Fellow at The George Institute for Global Health since 2015. Previously, he was Director of Research for East Metropolitan Health Service, WA Health from 2017 to 2020.

Professor Hillis specializes in cardiovascular epidemiology and clinical trials in cardiovascular medicine, with key interests in heart failure, aortic stenosis, hypertension, acute coronary syndromes, and perioperative cardiac care. He has authored over 250 publications in leading journals and served as principal investigator or co-investigator on grants exceeding $35 million over the past five years from funders including NHMRC, Heart Foundation, and MRFF. His research influences clinical practice through leadership in trials such as EASY AS, EVEREST, CardioCHARGE, and REMOTE CARE. Notable awards include the WA Health Research Excellence Award, National Heart Foundation Ross Hohnen Prizes for Research Excellence in 2014 and 2018, CSANZ Clinical Trials Prize 2020 for the STAT Chest Pain study, Best Clinical Research Paper from Royal Perth Hospital Research Foundation in 2019, and Heart Foundation President's Award in 2015. Key publications comprise "Bioprosthetic vs. mechanical prostheses in patients aged 50–70 years undergoing aortic valve replacement surgery: outcomes analysis from propensity score matching" (European Heart Journal Open, 2026), "Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a multicentre, double-blind, randomised, controlled, phase 3 trial" (The Lancet Respiratory Medicine, 2026), and "Clinical impact of cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries: a prospective multicentre cohort study" (Heart, 2026). He chairs the Cardiac Society of Australia and New Zealand Clinical Trials Committee, serves on its Professional and Ethical Standards Committee, and is an executive member of the Australian and New Zealand Alliance for Cardiovascular Trials network, contributing to multiple trial steering, endpoint adjudication, and data safety monitoring committees.